14 - INSPIRE: Final Results from a Phase 3, Open-Label, Pivotal Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension
Presentation Number
14
Session Name
SESSION 05 - ORAL: Pulmonary Hypertension: Where We're Going We Don't Need Roads
Date
Wed, Apr 22, 2020
Time
10:30 AM - 12:15 PM
Authors
- N. Hill, Boston, MA, United States of America
- J. Feldman, Phoenix, AZ, United States of America
- S. Sahay, Houston, TX, United States of America
- D. Levine, San Antonio, TX, United States of America
- R. Roscigno, Morrisville, NC, United States of America
- T. Vaughn, Morrisville, NC, United States of America
- T. Bull, Aurora, CO, United States of America